Tenecteplase
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1373 publications
Association of Successful Recanalization and Functional Outcomes in Minor Ischemic Stroke With Proven Occlusion: A Secondary Analysis of TEMPO-2 Trial.
Journal: Stroke
Published: June 19, 2026
Predictors and Consequences of Serious Adverse Events in Patients Treated With Thrombolysis: A Prespecified Secondary Analysis of the AcT Trial.
Journal: Journal of the American Heart Association
Published: June 09, 2026
Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.
Journal: Continuum (Minneapolis, Minn.)
Published: June 03, 2026
Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: June 01, 2026
In basilar artery occlusion, tenecteplase within 24 h of symptom onset improved functional outcome vs. usual care at 90 d.
Journal: Annals of internal medicine
Published: June 01, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion After Ischemic Stroke-Reply.
Journal: JAMA
Published: May 27, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion After Ischemic Stroke.
Journal: JAMA
Published: May 27, 2026
Association of 24-Hour Computed Tomography Infarct Density on Functional Outcomes in Stroke: Secondary Analysis From the AcT Trial.
Journal: Journal of the American Heart Association
Published: May 25, 2026
Thrombolysis for pulmonary embolism: A network meta-analysis.
Journal: Journal of the Intensive Care Society
Published: May 22, 2026
When Time Precludes Certainty: Intravenous Tenecteplase for Acute Global Aphasia in a Young Woman Along With Post-acute Diagnostic Reorientation.
Journal: Cureus
Published: May 20, 2026
Last Updated: 06/30/2026